Inhaled iloprost is a drug from the group of prostacyclins used in the treatment of pulmonary arterial hypertension. Its efficacy and safety have allowed its use as monotherapy and combination therapy. This review describes the product characteristics, amenable to treatment groups, and updated clinical evidence of drug use.
Keywords: Combination therapy; Hipertensión arterial pulmonar; Mexico; México; Prostanoides; Prostanoids; Pulmonary arterial hypertension; Pulmonary vasodilators; Tratamiento combinado; Vasodilatadores pulmonares.
Copyright © 2013 Instituto Nacional de Cardiología Ignacio Chávez. Published by Masson Doyma México S.A. All rights reserved.